Recent Finacing
Recent Raise
Zenas BioPharma is a clinical-stage biopharmaceutical company in Waltham, MA developing obexelimab, a bifunctional CD19/FcγRIIb antibody, across global Phase 2–3 programs for autoimmune and inflammatory diseases.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
